Literature DB >> 27287777

Two Unrelated Burkitt Lymphomas Seven Years Apart in a Patient With X-Linked Lymphoproliferative Disease Type 1 (XLP1).

Delu Zhou1, Christian N Paxton2, Todd W Kelley3, Zeinab Afify4, Sarah T South3, Rodney R Miles5.   

Abstract

OBJECTIVES: We describe a rare case of a male child with X-linked lymphoproliferative disease type 1 (XLP1) who presented with Burkitt lymphoma (BL) when he was 6 years old, achieved a complete response to therapy, and developed a second BL after seven years.
METHODS: Diagnostic H&E stained slides and ancillary studies were reviewed for both lymphomas. B-cell clonality by PCR and SNP array studies were performed on both specimens.
RESULTS: Both lymphomas were Epstein-Barr virus (EBV) negative. Flow cytometry showed λ light chain restriction in the initial BL and κ light chain restriction in the subsequent BL. B-cell clonality testing indicated that the two lymphomas are not clonally related. SNP array analysis of the second BL showed genomic changes that were not present in the first BL.
CONCLUSIONS: These results confirm that these two tumors represent unrelated BLs. Pathologists and clinicians should be aware that second lymphomas in XLP1 patients may represent new neoplasms rather than late relapses. © American Society for Clinical Pathology, 2016. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  B-cell clonality; Burkitt lymphoma; SNP array analysis; X-linked lymphoproliferative disease type 1

Mesh:

Substances:

Year:  2016        PMID: 27287777     DOI: 10.1093/ajcp/aqw036

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  1 in total

1.  A recurrent clonally distinct Burkitt lymphoma case highlights genetic key events contributing to oncogenesis.

Authors:  Dominique Penther; Pierre-Julien Viailly; Sylvain Latour; Pascaline Etancelin; Elodie Bohers; Hélène Vellemans; Vincent Camus; Anne Lise Menard; Sophie Coutant; Hélène Lanic; Emilie Lemasle; Fanny Drieux; Liana Veresezan; Philippe Ruminy; Anna Raimbault; Jean Soulier; Thierry Frebourg; Hervé Tilly; Fabrice Jardin
Journal:  Genes Chromosomes Cancer       Date:  2019-03-27       Impact factor: 5.006

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.